980
Views
0
CrossRef citations to date
0
Altmetric
Author's Views

A novel role for TTK in homologous recombination: implications for breast cancer radiosensitivity

ORCID Icon & ORCID Icon
Article: 1737771 | Received 21 Feb 2020, Accepted 27 Feb 2020, Published online: 19 Mar 2020

References

  • Atlanta ACS. Cancer facts & figures 2020. Am Can Soc. 2020;1:12.
  • Kyndi M, Sorensen FB, Knudsen H, Overgaard M, Nielsen HM, Overgaard J. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol. 2008;26(9):1–3. doi:10.1200/JCO.2007.14.5565.
  • Lowery AJ, Kell MR, Glynn RW, Kerin MJ, Sweeney KJ. Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype. Breast Cancer Res Treat. 2012;133(3):831–841. doi:10.1007/s10549-011-1891-6.
  • Chandler BC, Moubadder L, Ritter CL, Liu M, Cameron M, Wilder-Romans K, Zhang A, Pesch AM, Michmerhuizen AR, Hirsh N, et al. TTK inhibition radiosensitizes basal-like breast cancer through impaired homologous recombination. J Clin Invest. 2020;130(2):958–973. doi:10.1172/JCI130435.
  • Poch O, Schwob E, de Fraipont F, Camasses A, Bordonné R, Martin RP. RPK1, an essential yeast protein kinase involved in the regulation of the onset of mitosis, shows homology to mammalian dual-specificity kinases. Mol Gen Genet MGG. 1994;243(6):641–653. doi:10.1007/BF00279573.
  • Musacchio A, Salmon ED, Musacchio A, Salmon ED. The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol. 2007;8(5):379–393. doi:10.1038/nrm2163.
  • Faesen AC, Thanasoula M, Maffini S, Breit C, Müller F, van Gerwen S, Bange T, Musacchio A. Basis of catalytic assembly of the mitotic checkpoint complex. Nature. 2017;542(7642):498–502. doi:10.1038/nature21384.
  • Mason JM, Wei X, Fletcher GC, Kiarash R, Brokx R, Hodgson R, Beletskaya I, Bray MR, Mak TW. Functional characterization of CFI-402257, a potent and selective Mps1/TTK kinase inhibitor, for the treatment of cancer. Proc National Acad Sci. 2017;114(12):3127. doi:10.1073/pnas.1700234114.
  • Thu KL, Silvester J, Elliott MJ, Ba-alawi W, Duncan MH, Elia AC, Mer AS, Smirnov P, Safikhani Z, Haibe-Kains B, et al. Disruption of the anaphase-promoting complex confers resistance to TTK inhibitors in triple-negative breast cancer. Proc National Acad Sci. 2018;115(7):E1570. doi:10.1073/pnas.1719577115.
  • Cruz C, Castroviejo-Bermejo M, Gutiérrez-Enríquez S, Llop-Guevara A, Ibrahim YH, Gris-Oliver A, Bonache S, Morancho B, Bruna A, Rueda OM, et al. RAD51 foci as a functional biomarker of homologous recombination repair and PARP inhibitor resistance in germline BRCA-mutated breast cancer. Ann Oncol. 2018;29(5):1203–1210. doi:10.1093/annonc/mdy099.